ParexelAI™: Accelerate Development, Expand Capacity, Improve Outcomes

Faster delivery that's reliable

ParexelAI represents a transformative opportunity for companies seeking to accelerate their path to patients. This innovative, proprietary suite of AI services and capabilities fundamentally reimagines clinical development by combining our operational excellence with cutting-edge AI technology. By partnering with Parexel, you gain access to a fully AI-enabled clinical development partner that delivers greater speed, quality, and efficiency.

Supported by strategic partnerships

• Through its strategic partnership with Paradigm Health, Parexel is transforming patient identification and trial access across a network of 800+ research sites and 2,100+ provider locations.
• Working wit Weave Bio, Parexel is reducing Investigational New Drug (IND) and New Drug Application (NDA) authoring timelines by 60% through regulatory automation, helping sponsors reach high-stakes regulatory decisions sooner than previously possible.
• Parexel was the first CRO to adopt Palantir’s Artificial Intelligence Platform, which serves as the backbone for its AI-enabled clinical operations, supporting faster, higher-quality study delivery.
• Parexel also leverages partnerships with other leading technology companies to access the latest innovations and provide its customers with a truly AI-enabled clinical development partner.

Advantages

Trusted expertise

Risk managed, compliance assured — human-led AI combines regulatory rigor with intelligent automation to drive operational excellence and protect data integrity.

Empowered workforce

AI solutions elevate experts to focus on problem-solving and higher-impact challenges to
deliver solutions others don’t see.

Unlocked insights

Drive smarter decisions and faster trials — AI surfaces predictive insights at every stage, reducing protocol risk, study delays, and costly trial amendments.

High-performance delivery

Consistent operational excellence, delivered at speed — end-to-end AI eliminates rework and manual bottlenecks to accelerate site activation, enrollment, data analysis and submission timelines.

Best-in-class collaborations

An intentional partner strategy with best-of-breed providers unites domain expertise with access to leading AI platforms for solutions that drive innovation, reach new patients and deliver speed with precision.

AI drives speed without shortcuts across the clinical trial lifecycle

Early planning

• Study design optimizer
  Impact: ;Informs fit-for-purpose protocol design through rapid analysis of similar public protocols​

• Protocol abstraction
  Impact: Expedites insight identification for protocol design from past Parexel protocols

• Study companion
  Impact: Analyzes historical data from past Parexel projects to optimize early feasibility

Study start-up

• Patient recruitment​
  Impact: Speeds patient recruitment & time to first patient in (Paradigm Health)​

• Patient motivation assessment​
  Impact: Identifies patients and measures motivation to inform protocol design impact and patient engagement strategies

• Site feasibility​
  Impact: Rapid data analysis across global site networks enables fast site identification based on protocol requirements​

• Contract Automation​
  Impact: Uses historical data to automate draft generation and reduce site contracting timelines​

Delivery

• Regulatory compliance
  Impact: Enables proactive compliance by automating Clinical Trials Information System (CTIS) monitoring

• Study Data Tabulation Model (SDTM) Generation​
  Impact: Automates creation of SDTM datasets, disparate data integration and streamlines data workflows

• Safety processing
  Impact: Automates safety literature review, enabling earlier signal detection

• Safety Individual Case Safety Report (ICSR) Intake​
  Impact: Accelerates delivery timelines for individual Clinical Study Reports (CSRs)

• Resource management​
  Impact: Enables precision resourcing for full-service outsourcing and functional service provider delivery models

Closeout

• R Biostatistical Platform​
  Impact: Automates R workflows to ensure regulatory-ready analytics

• Statistical Analysis System (SAS) Code Reviewer​
  Impact: Drives faster quality review of SAS coding

• Clinical Study Report (CSR) Generation​
  Impact: Generates quality control for CSR draft, resulting in 30% CSR timeline reduction​

How we're different

• Our customers gain an “insight advantage” in navigating AI regulatory requirements across global markets.
• AI will never replace our domain expertise. Every AI solution requires human decision-making and is assistive by design.
• End-to-end coverage – Solutions across the entire trial lifecycle.